Table 2 Low ATM expression independently predicts poor disease survival in a multivariate model in the HNBC cohort

A

tATM (low vs high)

<0.001

14.16 (5.17-38.83)

Tumor size (T3/4 vs T1/2)

<0.001

9.44 (3.26-27.32)

LN status (+ vs -)

0.03

4.35 (1.11-17.01)

LVI (+ vs -)

0.08

2.51 (0.91-6.91)

Grade (3 vs 1/2)

0.48

1.58 (0.44-5.71)

Age (>53 vs <53)

0.51

1.34 (0.56-3.21)

B

nATM (low vs high)

<0.001

7.43 (2.95-18.76)

Tumor size (T3/4 vs T1/2)

<0.001

6.39 (2.36-17.30)

LN status (+ vs -)

0.11

2.84 (0.80-10.07)

LVI (+ vs -)

0.07

2.46 (0.92-6.60)

Grade (3 vs 1/2)

0.55

1.47 (0.41-5.25)

Age (>53 vs <53)

0.32

1.55 (0.66-3.66)

C

csATM (low vs high)

<0.001

4.72 (1.95-11.42)

Tumor size (T3/4 vs T1/2)

0,01

3.45 (1.27-9.36)

LN status (+ vs -)

0.24

2.07 (0.61-7.00)

LVI (+ vs -)

0.57

1.33 (0.50-3.55)

Grade (3 vs 1/2)

0.24

2.29 (0.58-9.08)

Age (>53 vs <53)

0.71

1.20 (0.46-3.10)